ZTS 株価分析 — Zoetis Inc (Healthcare >> Drug Manufacturers - Specialty & Generic)
ZTS に関するよくある質問
ZTSのPER(株価収益率)は?
Zoetis Inc(ZTS)は現在PER 12.26倍で取引されています。
ZTSのROE(自己資本利益率)は?
Zoetis IncのROEは81.75%です。
ZTSの配当利回りは?
Zoetis Incの配当利回りは2.67%です。
ZTSの品質スコア(Quality Score)は?
当社のAIはZTSの総合財務品質を100点中77点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ZTSは今が買い時ですか?
当社AIのタイミングスコアは100点中51点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ZTSはどのセクターに属しますか?
Zoetis IncはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます(NYSE市場)
ZTS AI Analysis Summary
Our AI summary for ZTS: Zoetis Inc (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 12.26, ROE of 81.75%, a dividend yield of 2.67%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 77.10
Price
-0.19
(-0.25%)
Day Change
|
|
|---|
ZTS, ファンダメンタルスコアはgood ( ファンダメンタル = 77) but テクニカルスコアは ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROAがROEに比べて低い
ROAの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are ok , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
63% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
283
|
| Magic Formula Rank by ROE |
283
|
| Magic Formula Rank by ROIC |
327
|
| Price | 77.10 |
| PBV / Sector |
10.02 / 9.54
|
| Earning Per Share | 6.29 |
| PE / Sector |
12.26 / 28.71
GOOD
|
| PEG or PE/Growth / Sector |
1.19 / -0.10
|
| Average 1M Daily Value |
359.18 M
GREAT
|
| Average 1W Daily Value |
378.80 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
79% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-04 08:02:26 |
| Symbol | ZTS |
| Name | ZOETIS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 419.23 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 32,402.14 / 10,605.93 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 10 Sylvan Way, Parsippany, NJ, United States, 07054
Phone: 973 822 7000
Website: https://www.zoetis.com
Employees: 14,500
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google